Novo Nordisk’s license on semaglutide is readied to end in March throughout numerous markets.
发布者：BY MARKETWIRE，转转请注明出处：https://robotalks.cn/novo-nordisk-to-face-rising-threat-from-generic-competitors/
Novo Nordisk to face rising threat from generic competitors
赞 (0)
关于作者
相关推荐
-
The best Cyber Monday deals you can shop right now
Photo: Elen Winata for The Brink Black Friday mores than, however you can still conserve a lot on gizmos, video games, and various other equipment for Cyber Monday. Continue readin…
-
Marketers discuss their first-party data strategies
First-party information is still essential to customization and client experience, whatever winds up occurring to third-party cookies.The blog post Marketing professionals review t…
-
Brenmiller Energy Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification
ROSH HA’AYIN, Israel–( COMPANY CORD)– $BNRG– Brenmiller Power Ltd. (” Brenmiller Power” or the “Firm”) (Nasdaq: BNRG), a leading wor…
-
Stats indicate over 50% of manufacturers and engineers may outsource marketing in 2025
In 2024, 46% of UK firms outsourced some aspect of their advertising, with the determine rising to 50% for firms who function business-to-business (B2B), together with corporations…
-
HTC unveils Vive Eagle AI-enabled smart eyewear to take on Meta
HTC Corp., a worldwide business with a concentrate on immersive modern technology, today introduced the launch of a brand-new line of wearable fabricated intelligence-enabled eyegl…
